SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Bill Wexler's Dog Pound
REFR 1.560-1.9%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bob Trocchi who wrote (8495)1/18/2002 9:53:09 PM
From: BDR  Read Replies (1) of 10293
 
Bob-

Thanks for the heads up on VVUS. I have no idea how CE Unterberg Towbin could justify a double in 12 months based on starting a Phase I trial.

"This is a significant first step in the clinical development of TA-1790," stated Dr. John Dietrich, Vice President of Research and Development at VIVUS. "The trial that we will conduct is designed to assess the acute safety and efficacy of orally administered TA-1790 in subjects with erectile dysfunction."
siliconinvestor.com

It is a PDE5 inhibitor like Viagra so it will probably work but by the time they go through three years or more of the appropriate studies it will be only one of three, four or more PDE5 inhibitors on the market by then with the others backed but much wealthier and smarter (based on Vivus's track record) companies. Actually given the pathetic record of the company one has to wonder what is wrong with TA-1790. If it was any good wouldn't a real pharmaceutical company have licensed it by now?

From their last 10-Q:
"During 1998, VIVUS, Inc. experienced a significant decline in market demand for MUSE® due to the market launch of sildenafil,
the first oral treatment for erectile dysfunction."

Funny, I thought it was because MUSE didn't work worth a damn.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News